Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
11/2000
11/22/2000EP1053041A1 Assessment and control of acoustic tissue effects
11/22/2000EP1052998A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
11/22/2000EP1052976A1 Method for ultrasound triggered drug delivery
11/21/2000US6150327 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/21/2000US6149931 Applying over and around retinal break a non-toxic polymer formulation comprising polymer precursor that is a poly(ethylene glycol) based polymer precursor, and transforming the polymer formulation into a gel-like coat
11/21/2000US6149671 Laser/sensitizer assisted immunotherapy
11/16/2000WO2000067917A1 Permeabilizing biofilms
11/16/2000WO2000067764A2 Improved method for treating mammals with modified mammalian blood
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000033874B1 Boron neutron capture therapy using pre-targeting methods
11/16/2000DE19922052A1 Determining the effect of chemotherapy and/or radiotherapy on malignancies comprises determining the expression profiles of or mutations in genes that regulate apoptosis and/or cell growth
11/16/2000CA2373447A1 Permeabilizing biofilms
11/16/2000CA2372624A1 Improved method for treating mammals with modified mammalian blood
11/15/2000EP1051421A1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy
11/15/2000CN1058388C Stable freeze dried polyhematoporphyrin ether/ester composition
11/14/2000US6147207 Bonding polyether chain ends to alcohol-reactive moieties of a porphyrin, then partially hydrogenating the porphyrin to yield a chlorin
11/14/2000US6147195 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146657 Liposome filled with an insoluble gas and a soluble gas, wherein said liposome comprises phosphatidylcholine(s), phosphatidylethanolamine(s), and phosphatidic acid(s); use in ultrasonic or magnetic resonance imaging
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000028813A9 Treatment of myelogenous leukemia
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000CA2368748A1 X-ray guided drug delivery
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143287 Applying a mixture of liposome and phthalocyanine; applying light source
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6142939 Microporation of human skin for drug delivery and monitoring applications
11/06/2000CA2271190A1 Improved method for treating mammals with modified mammalian blood
11/02/2000WO2000064476A2 Immuno-adjuvant pdt treatment of metastatic tumors
11/02/2000WO2000064439A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000EP0952873A4 Targeted hysteresis hyperthermia as a method for treating diseased tissue
11/02/2000CA2370600A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
10/2000
10/31/2000USRE36939 A booster comprising a plenty of microbubbles of a gas and drug in a liquid, diffusion and penetration of the medicament into the body by applying ultrasound; transdermal drug delivery
10/31/2000US6140314 Selective and non-invasive visualization or treatment of vasculature
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062808A2 Cobalamin conjugates useful as antitumor agents
10/26/2000WO2000062788A2 Treatment of hypersensitivity reaction disorders
10/26/2000CA2370453A1 Treatment of hypersensitivity reaction disorders
10/26/2000CA2370419A1 Cobalamin conjugates useful as antitumor agents
10/25/2000EP0717617B1 Active principle and gas containing microparticles
10/24/2000US6136841 Complexes; medical diagnosis
10/24/2000US6136308 Treatment of stress and preconditioning against stress
10/24/2000US6135976 Method, device and kit for performing gene therapy
10/19/2000WO2000061585A2 1,3-dipolar cycloadditions to polypyrrolic macrocycles
10/19/2000WO2000061584A1 IMPROVED β,β,-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, AND BACTERIOCHLORINS
10/19/2000WO2000061221A1 Method of providing cosmetic/medical therapy
10/19/2000WO2000061187A1 Radioenhanced cancer treatment using orally administered camptothecin derivatives
10/19/2000WO2000061162A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
10/19/2000CA2369426A1 Radioenhanced cancer treatment using orally administered camptothecin derivatives
10/19/2000CA2369381A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
10/19/2000CA2356128A1 Method of providing cosmetic/medical therapy
10/19/2000CA2269364A1 Treatment of inflammatory and allergic disorders
10/18/2000EP1044021A1 Enhanced transport using membrane disruptive agents
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000CN1270630A Method of treating leukocytes, leukocyte compositions and methods of use thereof
10/18/2000CN1270062A Glycobiazole metal salt as synergist for radiotherapy or chemicotherapy and its preparing process and application
10/12/2000WO2000059505A1 Inhibitors for vascular reconstriction after angioplasty
10/12/2000WO2000059504A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000WO2000033874A3 Boron neutron capture therapy using pre-targeting methods
10/12/2000DE19905094C1 Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel Gadolinium (III) complexes and the use thereof for radiation therapy Two step forms and pharmaceutical compositions containing them
10/12/2000CA2366850A1 Method for the treatment of neurological or neuropsychiatric disorders
10/11/2000EP1043316A2 Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
10/11/2000EP1041985A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
10/11/2000CN1269729A Composition for releiving inflamation and product thereof
10/04/2000EP1040825A1 Means for diagnosing bladder carcinoma
10/03/2000US6128524 A medicine including a mixture of an infra red fluorescent agent and a photosensitive agent both remain in a diseased part in a depth of an eye fundus for clogging blood vessels by laser beam radiation to bring a photochemical change
09/2000
09/28/2000WO2000056774A1 Methods of using bioelastomers
09/28/2000WO2000056299A2 The use of amifostine for the protection against tumor metastasis formation
09/27/2000EP1037673A1 Charged lipids and uses for the same
09/27/2000EP1037531A1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy
09/27/2000EP0881874A4 Viral inactivation treatment of red blood cells using phthalocyanines and red light
09/27/2000CN1268059A Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
09/26/2000US6125295 Pharmaceutically enhanced low-energy radiosurgery
09/26/2000US6124342 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
09/21/2000WO2000055133A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000WO2000054794A1 Wafer delivery system
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000CA2368150A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/19/2000US6121278 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
09/19/2000US6120768 Dota-biotin derivatives
09/19/2000US6120751 Charged lipids and uses for the same
09/19/2000US6120531 Physiotherapy fiber, shoes, fabric, and clothes utilizing electromagnetic energy
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053170A1 Means for diagnosing and treating carcinoma
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
09/13/2000EP1033972A1 Drug delivery system with two-step targeting
09/12/2000US6117862 Model and method for angiogenesis inhibition
09/12/2000US6117858 For specific delivery of biologically active substances to achieve lower doses and for improved efficacy with drugs such as oligonucleotides and polynucleotides with problems in achieving therapeutic concentrations at targeted organs
09/12/2000US6117852 Comprising submicron boron powder, lipiodol, lecithin and unsaturated fatty acid; for treating hepatoma
09/08/2000WO2000052714A1 Heating of magnetic material by hysteresis effects
09/08/2000WO2000052122A1 Detergent compositions comprising photobleaching delivery systems
09/08/2000WO2000052101A1 A composition comprising a photo-oxidising agent and uses of the agent
09/08/2000WO2000051639A2 Treatment of neoplastic diseases by radiation
09/08/2000WO2000051638A1 Photodynamic therapy in combination with apoptosis inducing factors
09/08/2000CA2365403A1 Heating of magnetic material by hysteresis effects
09/06/2000EP1032321A4 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
09/06/2000EP1032321A1 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 95